logo

English
                 

News Aleve may be safer for heart

2014.01.29 03:28

Rover Views:1578

AP January 28, 2014, 11: 06 PM


Aleve may be safer on heart than

other anti-inflammatory drugs



WASHINGTON - Federal health officials say the pain reliever in Aleve may be safer on the heart than other popular anti-inflammatory drugs taken by millions of Americans.


A Food and Drug Administration review posted online Tuesday said naproxen - the key ingredient in Aleve and dozens of other generic pain pills - may have a lower risk of heart attack and stroke than rival medications like ibuprofen, sold as Advil and Motrin. FDA staffers recommend relabeling naproxen to emphasize its safety.


The safety review was prompted by a huge analysis published last year that looked at 350,000 patients taking various pain relievers. The findings suggest naproxen does not carry the same heart risks as other medications in the class known as nonsteroidal anti-inflammatory drugs, or NSAIDs.

The agency released its memo ahead of a public meeting next month where outside experts will discuss the new data and whether naproxen should be relabeled. The agency is not required to follow the group's advice, though it often does.

If ultimately implemented, the labeling changes could reshape the multibillion-dollar market for drugs used to treat headaches, muscle pain and arthritis.


The change could make Aleve and other naproxen drugs the first choice for patients with a higher risk for heart problems, according to Ira Loss, a pharmaceutical analyst with Washington Analysis. But he added that all NSAIDs will continue to carry warnings about internal bleeding and ulceration, a serious side effect that is blamed for more than 200,000 hospital visits every year.


The FDA meeting is the latest chapter in an ongoing safety review of NSAIDs that stretches back to 2004, when Merck& Co Inc. pulled its blockbuster pain reliever Vioxx off the market due to links to heart attack and stroke.


Vioxx was part of a subset of newer NSAIDs designed to be easier on the stomach. But in the wake of the Vioxx recall, the FDA beefed up warnings about heart safety risks on all drugs in the class, including Motrin, Advil, Aleve and Celebrex. Pfizer's Celebrex is the only drug from the same class as Vioxx that remains on the market.


Current labeling warns that taking NSAIDs long-term can increase the risk of heart attack and stroke. Patients and doctors are advised to take the drugs for the shortest time period possible.

But FDA staffers said in Tuesday's memo that labeling should be changed "to reflect the more favorable cardiovascular risk profile of naproxen."

Bayer spokesman Chris Loder said in a statement that naproxen's safety and efficacy is "based on clinical trials, observational studies and clinical and real world use for more than 38 years." The German-based conglomerate is one of a half-dozen pharmaceutical manufacturers presenting at the FDA meeting, scheduled for Feb. 10 and 11.


The FDA also disclosed Tuesday that it is considering halting a long-term study comparing the safety of naproxen, ibuprofen and Celebrex, the prescription painkiller from Pfizer.

Given that recent data show a lower rate of heart attack and stroke for naproxen, FDA staffers say patients in the trial are being "exposed to an undue risk."

Launched in 2006 by Pfizer, which makes both Celebrex and Advil, the PRECISION study is expected to be completed by late 2015. The company said in a statement that "current evidence does not support" changes to the labeling of its drugs.


Celebrex was New York-based Pfizer's fourth-best-selling drug last year, with sales of $2.92 billion.

No. Subject Date Author Last Update Views
Notice How to write your comments onto a webpage [2] 2016.07.06 운영자 2016.11.20 18194
Notice How to Upload Pictures in webpages 2016.07.06 운영자 2018.10.19 32348
Notice How to use Rich Text Editor [3] 2016.06.28 운영자 2018.10.19 5925
Notice How to Write a Webpage 2016.06.28 운영자 2020.12.23 43841
» Aleve may be safer for heart [1] 2014.01.29 Rover 2014.01.29 1578
193 [시계탑] 2014 First Quarter PDF Edition 2014.01.20 운영자 2014.01.20 2464
192 [서울소식] 함춘 Inside - 2014년 January Edition [2] 2014.01.09 운영자 2014.01.09 2561
191 한국외교부 홍보 전달 - 대한민국의 영토, 독도 [3] 2014.01.03 운영자 2014.01.03 2516
190 Be aware ! Very clever credit card scam [1] 2013.12.23 Rover 2013.12.23 2366
189 [Newsletter] 함춘인사이드 게재 시작 2013.12.19 운영자 2013.12.19 3086
188 시카고 동창회 소식 [4] 2013.12.14 노영일*68 2013.12.14 3710
187 시카고 동창회 소식 [2] 2013.12.02 노영일*68 2013.12.02 3950
186 시카고 동창회 소식 - 서울미대 동문전 2013 [5] 2013.11.03 노영일*68 2013.11.03 3559
185 <b>[시계탑] Sigetop Archives - All Years since 2008</b> 2013.10.25 운영자 2013.10.25 4363
184 <b>[시계탑] Sigetop PDF Version, 2013 4th Quarter</b> 2013.10.25 운영자 2013.10.25 3334
183 建軍65周年 國軍의 날 記念式 [2] 2013.10.03 Rover 2013.10.03 3802
182 Our family in LPGA Solheim Cup !! [8] 2013.08.19 운영자 2013.08.19 3898
181 서울의대 동창회 2014 학술대회 알라스카 크루즈 변경사항 2013.08.19 김성환*71 2013.08.19 3644
180 일본 정부는 Fukushima nuclear waste water 가 바다로 새는것을 감추고있다 [2] 2013.08.11 운영자 2013.08.11 2375
179 Fukushima Radiation Proves Less Deadly Than Feared.....Another Look At Fukushima [10] 2013.08.07 김영철*61 2013.08.07 3454
178 <b>[시계탑] Sigetop Archives - All Years since 2008</b> 2013.07.24 운영자 2013.07.24 5182
177 <b>Sigetop 2013 Third Quarter PDF Edition 2013.07.24 운영자 2013.07.24 3625
176 시카고 동창회 소식 [2] 2013.05.26 노영일*68 2013.05.26 5213
175 시카고 동창회 소식 [6] 2013.05.21 노영일*68 2013.05.21 5325